Table 1 Baseline characteristics of patients with diabetic kidney disease.
Variable | Stages of chronic kidney disease | P | ||
|---|---|---|---|---|
3 (N = 56) | 4 (N = 41) | 5 (N = 44) | ||
Age, years | 67 (58–74) | 66 (59–71) | 65 (55–69) | 0.334 |
Male, n (%) | 42 (75) | 24 (59) | 37 (84) | 0.027 |
Smoking, pack/years | 0.7 (0.0–3.0) | 0.0 (0.0–2.0) | 2.1 (0.0–4.4) | 0.067 |
Nonsmoker, n (%) | 25 (45) | 21 (51) | 15 (34) | 0.465 |
Ex-smoker | 24 (43) | 13 (32) | 20 (46) | |
Current smoker | 7 (12) | 7 (17) | 9 (20) | |
Alcohol use, n (%) | ||||
≤ 1/month | 45 (80) | 36 (88) | 37 (84) | 0.720 |
1/week | 4 (7) | 1 (2) | 1 (2) | |
2–3/week | 7 (13) | 3 (7) | 5 (12) | |
≥ 4/week | 0 (0) | 1 (3) | 1 (2) | |
BMI, kg/m2 | 25.3 (22.5–27.1) | 25.0 (21.9–28.7) | 25.5 (23.0–27.8) | 0.827 |
Normal, n (%) | 15 (27) | 13 (32) | 11 (25) | 0.963 |
Overweight, n (%) | 10 (18) | 7 (17) | 9 (20) | |
Obesity, n (%) | 31 (55) | 21 (51) | 24 (55) | |
SBP, mmHg | 130 (120–140) | 132 (127–142) | 137 (124–148) | 0.303 |
DBP, mmHg | 76 (67–82) | 76 (65–84) | 72 (65–77) | 0.281 |
DM duration, years | 19.0 (13.3–27.0) | 19.0 (14.0–27.5) | 17.5 (11.3–22.0) | 0.393 |
Comorbidities, n (%) | ||||
MI | 4 (7) | 5 (12) | 2 (5) | 0.410 |
CHF | 2 (4) | 4 (10) | 6 (14) | 0.179 |
PAOD | 5 (9) | 3 (7) | 3 (7) | 0.918 |
Stroke | 11 (20) | 9 (22) | 6 (14) | 0.870 |
Dementia | 0 (0) | 2 (5) | 0 (0) | 0.083 |
COPD | 2 (4) | 0 (0) | 1 (2) | 0.779 |
Malignancy | 6 (11) | 5 (12) | 6 (14) | 0.905 |
Chronic liver disease | 13 (23) | 9 (22) | 8 (18) | 0.824 |
Peptic ulcer disease | 0 (0) | 3 (7) | 5 (11) | 0.028 |
CCI score | 6.0 (5.0–7.0) | 6.0 (5.0–7.0) | 7.0 (6.0–8.0) | < 0.001 |
Low, n (%) | 5 (9) | 1 (2) | 0 (0) | < 0.001 |
Moderate, n (%) | 35 (62) | 22 (54) | 12 (27) | |
High, n (%) | 10 (18) | 12 (29) | 14 (32) | |
Very high, n (%) | 6 (11) | 6 (14) | 18 (41) | |
PSQI-K score | 2.0 (1.0–5.0) | 2.0 (1.0–5.5) | 4.0 (2.3–8.0) | 0.002 |
Good sleeper, n (%) | 43 (77) | 31 (76) | 27 (61) | 0.189 |
Poor sleeper, n (%) | 13 (23) | 10 (24) | 17 (39) | |
Anxiety score | 2.0 (1.0–3.0) | 3.0 (1.0–4.0) | 2.0 (1.0–6.0) | 0.427 |
Normal, n (%) | 53 (95) | 38 (93) | 39 (89) | 0.695 |
Borderline, n (%) | 3 (5) | 2 (5) | 4 (9) | |
Abnormal, n (%) | 0 (0) | 1 (2) | 1 (2) | |
Depression score | 3.0 (2.0–5.0) | 4.0 (2.5–6.0) | 4.0 (1.0–8.0) | 0.259 |
Normal, n (%) | 50 (89) | 35 (85.5) | 32 (73) | 0.252 |
Borderline, n (%) | 4 (7) | 5 (12) | 8 (18) | |
Abnormal, n (%) | 2 (4) | 1 (2.5) | 4 (9) | |
IPAQ score | 1,680 (810–3,360) | 1,560 (120–3,360) | 840 (480–2200) | 0.263 |
Low, n (%) | 12 (21) | 15 (37) | 13 (29) | 0.122 |
Moderate, n (%) | 28 (50) | 14 (34) | 25 (57) | |
High, n (%) | 16 (29) | 12 (29) | 6 (14) | |
SF-36 score | 78.8 (71.0–82.1) | 70.5(56.4–81.5) | 69.8(56.9–81.6) | 0.029 |
Physical functioning | 90.0 (85.0–95.0) | 85.0 (62.5–95.0) | 85.0 (61.3–90.0) | 0.047 |
Role-physical | 75.0 (56.3–100.0) | 50.0 (25.0–100.0) | 50.0 (25.0–100.0) | 0.002 |
Bodily pain | 100.0 (90.0–100.0) | 100.0 (83.8–100.0) | 100.0 (81.9–100.0) | 0.277 |
Social functioning | 100.0 (90.6–100.0) | 100.0 (75.0–100.0) | 100.0 (87.5–100.0) | 0.260 |
Mental health | 72.0 (64.0–80.0) | 76.0 (64.0–80.0) | 72.0 (56.0–76.0) | 0.155 |
Role-emotional | 100.0 (66.7–100.0) | 100.0 (33.3–100.0) | 100.0 (41.7–100.0) | 0.244 |
Vitality | 50.0 (45.0–60.0) | 50.0 (45.0–62.5) | 50.0 (40.0–60.0) | 0.295 |
General health | 40.0 (21.3–65.0) | 40.0 (25.0–57.5) | 40.0 (21.3–60.0) | 0.991 |
PCS score | 78.8 (65.2–85.0) | 71.3 (52.8–82.5) | 65.0 (51.9–79.4) | 0.011 |
MCS score | 80.5 (67.5–83.9) | 74.4 (59.1–82.5) | 74.3 (51.7–82.9) | 0.208 |
Hb, g/dL | 12.7 (11.6–14.4) | 11.9 (10.6–12.7) | 11.1 (10.3–12.1) | < 0.001 |
eGFR, mL/min/1.73 m2 | 41 (37–47) | 22 (18–27) | 7 (6–11) | < 0.001 |
HbA1c, % | 6.9 (6.2–7.7) | 6.8 (6.4–7.8) | 6.5 (5.8–6.9) | 0.014 |
uPCR, mg/mg Cr | 0.97 (0.53–2.13) | 2.40 (1.08–4.44) | 3.78 (1.10–5.45) | 0.001 |